Abstract
Introduction: Over 2000 liver transplant candidates die each year while waiting for an organ. Living liver donor transplantation can play a significant role in expanding the availability of livers however, transplant programs must minimize risk to potential liver donors. The 2012 consensus document from the AST/ASTS/NATCA/UNOS Joint Societies Work Group states that clinically significant cardiovascular disease is a relative contraindication to live liver donation, with methodology, assessment and risk tolerance at the discretion of each transplant center. At the University of Colorado , we developed a protocol which integrates coronary CTA (CCTA) for cardiovascular risk assessment in potential living liver donors. We report our initial experience with this approach.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
